Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers

Volume: 92, Issue: 6, Pages: 606 - 615
Published: May 2, 2017
Abstract
We addressed uncertainties regarding hereditary leiomyomatosis and renal cell carcinoma ( HLRCC ) by exploring all French cases, representing the largest series to date. Fumarate hydratase ( FH ) germline testing was performed with Sanger sequencing and qPCR / MLPA . Enzyme activity was measured when necessary. We carried out whenever possible a pathology review of RCC and S‐(2‐succino)‐cysteine ( 2SC )/fumarate hydratase immunohistochemistry....
Paper Details
Title
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers
Published Date
May 2, 2017
Volume
92
Issue
6
Pages
606 - 615
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.